Fulton Breakefield Broenniman’s ASML ASML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.9M Buy
15,547
+963
+7% +$1.53M 1.82% 16
2026
Q1
$19.3M Sell
14,584
-569
-4% -$780K 1.26% 22
2025
Q4
$16.2M Sell
15,153
-227
-1% -$237K 1.02% 27
2025
Q3
$14.9M Sell
15,380
-339
-2% -$266K 0.96% 30
2025
Q2
$12.6M Sell
15,719
-276
-2% -$198K 0.85% 39
2025
Q1
$10.6M Buy
15,995
+246
+2% +$179K 0.77% 45
2024
Q4
$10.9M Buy
15,749
+3,009
+24% +$2.16M 0.78% 44
2024
Q3
$10.6M Buy
12,740
+12,151
+2,063% +$10.9M 0.74% 48
2024
Q2
$602K Sell
589
-25
-4% -$24K 0.04% 107
2024
Q1
$596K Buy
614
+53
+9% +$47K 0.05% 104
2023
Q4
$425K Sell
561
-27
-5% -$17.8K 0.03% 121
2023
Q3
$346K Buy
588
+27
+5% +$17.9K 0.03% 129
2023
Q2
$407K Sell
561
-14
-2% -$9.52K 0.03% 122
2023
Q1
$391K Sell
575
-30
-5% -$19.3K 0.03% 128
2022
Q4
$331K Sell
605
-7
-1% -$3.67K 0.03% 138
2022
Q3
$254K Buy
612
+152
+33% +$76.2K 0.02% 147
2022
Q2
$219K Sell
460
-21
-4% -$11.7K 0.02% 160
2022
Q1
$321K Buy
+481
New +$322K 0.03% 133

Other funds holding ASML

Fulton Breakefield Broenniman's ASML Position: Q2 2026 in Review

Fulton Breakefield Broenniman increased its ASML (ASML) stake by 6.6% in Q2 2026, buying an estimated $1.53M and bringing the position to 15,547 shares worth $30.9M. The position accounts for 1.82% of the portfolio, ranked #16.

Fulton Breakefield Broenniman first reported a position in ASML in Q1 2022 and has held it in 18 quarters since. 2,504 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Fulton Breakefield Broenniman held 15,547 shares of ASML worth $30.9M as of Q2 2026.
  • Fulton Breakefield Broenniman bought 963 ASML shares in Q2 2026, an estimated $1.53M.
  • ASML made up 1.82% of Fulton Breakefield Broenniman's portfolio in Q2 2026, its #16 holding.
  • Fulton Breakefield Broenniman first reported a position in ASML in Q1 2022 and has held it in 18 quarters since.
  • 2,504 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Fulton Breakefield Broenniman's 13F filing for Q2 2026, filed 3 Aug 2026.